<?xml version="1.0" encoding="UTF-8"?>
<p>With the increasing knowledge obtained through massive investigations on host immunity against IAV infection, promoting host immune responses not limited to antibody enhancement would have good prospects not only for vaccine design, but also for development of novel antiviral agents.</p>
